Leukemia | 2022
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.
Baccarani M, Bonifazi F, Soverini S, Castagnetti F, Gugliotta G, Saber W, Estrada-Merly N, Rosti G, Gale RP
PubMed
PMID: 35338251
Abstract
Related Articles
CIBMTR Study #: CK21-R1